GF
GRCL

Gabelli Funds’s Gracell Biotechnologies Inc. American Depositary Shares GRCL Stock Holding History

Gabelli Funds’s Portfolio GRCL Stock Details GRCL Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q1 		– Sell
-39,850
Closed -$400K – 1146
2023
Q4 		$400K Buy
+39,850
New +$181K ﹤0.01% 921

Gabelli Funds's GRCL Position: Q1 2024 in Review

Gabelli Funds sold out of Gracell Biotechnologies Inc. American Depositary Shares (GRCL) in Q1 2024, closing a stake of 39,850 shares — an estimated $400K sold.

Gabelli Funds first reported a position in GRCL in Q4 2023 and held it in 1 quarter. The position peaked at $400K in Q4 2023. 0 funds tracked by Wall St. Rank hold GRCL as of Q1 2024.

  • Gabelli Funds reported no remaining Gracell Biotechnologies Inc. American Depositary Shares position as of Q1 2024 after selling out during the quarter.
  • Gabelli Funds sold 39,850 Gracell Biotechnologies Inc. American Depositary Shares shares in Q1 2024, an estimated $400K.
  • Gabelli Funds first reported a position in Gracell Biotechnologies Inc. American Depositary Shares in Q4 2023 and held it in 1 quarter.
  • Gabelli Funds's Gracell Biotechnologies Inc. American Depositary Shares position peaked at $400K in Q4 2023.
  • 0 funds tracked by Wall St. Rank held Gracell Biotechnologies Inc. American Depositary Shares as of Q1 2024.

Based on Gabelli Funds's 13F filing for Q1 2024, filed 14 May 2024.